Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Unidirectional endobronchial valves for management of persistent air-leaks: results of a multicenter study.

Fiorelli A, D'Andrilli A, Cascone R, Occhiati L, Anile M, Diso D, Cassiano F, Poggi C, Ibrahim M, Cusumano G, Terminella A, Failla G, La Sala A, Bezzi M, Innocenti M, Torricelli E, Venuta F, Rendina EA, Vicidomini G, Santini M, Andreetti C.

J Thorac Dis. 2018 Nov;10(11):6158-6167. doi: 10.21037/jtd.2018.10.61.

2.

How Effective and Safe Is Bronchial Thermoplasty in "Real Life" Asthmatics Compared to Those Enrolled in Randomized Clinical Trials?

Arrigo R, Failla G, Scichilone N, La Sala A, Galeone C, Battaglia S, Benfante A, Facciolongo N.

Biomed Res Int. 2016;2016:9132198. Epub 2016 Sep 8.

3.

Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses.

Cacciotti G, Caputo B, Selvaggi C, la Sala A, Vitiello L, Diallo D, Ceianu C, Antonelli G, Nowotny N, Scagnolari C.

Virology. 2015 Nov;485:189-98. doi: 10.1016/j.virol.2015.07.015. Epub 2015 Aug 14.

4.

Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.

Efficace F, Fayers P, Pusic A, Cemal Y, Yanagawa J, Jacobs M, la Sala A, Cafaro V, Whale K, Rees J, Blazeby J; European Organization for Research and Treatment of Cancer Quality-of-Life Group (Patient-Reported Outcome Measurements Over Time in Oncology Registry).

Cancer. 2015 Sep 15;121(18):3335-42. doi: 10.1002/cncr.29489. Epub 2015 Jun 16.

5.

Purinergic signaling in atherosclerosis.

Ferrari D, Vitiello L, Idzko M, la Sala A.

Trends Mol Med. 2015 Mar;21(3):184-92. doi: 10.1016/j.molmed.2014.12.008. Epub 2015 Jan 27. Review.

PMID:
25637413
6.

Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey.

D'Arena G, Laurenti L, Coscia M, Cortelezzi A, Chiarenza A, Pozzato G, Vigliotti ML, Nunziata G, Fragasso A, Villa MR, Grossi A, Selleri C, Deaglio S, La Sala A, Del Poeta G, Simeon V, Aliberti L, De Martino L, Giudice A, Musto P, De Feo V.

Leuk Lymphoma. 2014 Apr;55(4):841-7. doi: 10.3109/10428194.2013.803223. Epub 2013 Oct 17.

PMID:
23829282
7.

Regulation of innate immunity by extracellular nucleotides.

Gorini S, Gatta L, Pontecorvo L, Vitiello L, la Sala A.

Am J Blood Res. 2013;3(1):14-28. Epub 2013 Jan 17.

8.

Regulation of collateral blood vessel development by the innate and adaptive immune system.

la Sala A, Pontecorvo L, Agresta A, Rosano G, Stabile E.

Trends Mol Med. 2012 Aug;18(8):494-501. doi: 10.1016/j.molmed.2012.06.007. Epub 2012 Jul 18. Review.

PMID:
22818027
9.

Immunoregulation through extracellular nucleotides.

Vitiello L, Gorini S, Rosano G, la Sala A.

Blood. 2012 Jul 19;120(3):511-8. doi: 10.1182/blood-2012-01-406496. Epub 2012 Jun 1.

10.

Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.

Morabito F, Hohaus S, Mammi C, Marcheselli L, Gentile M, Merli F, Montanini A, Stelitano C, La Sala A, Scalone R, Voso MT, Luminari S, Iannitto E, Gobbi P, Federico M.

Leuk Lymphoma. 2012 Mar;53(3):406-10. doi: 10.3109/10428194.2011.623254.

PMID:
21916526
11.

Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure.

Mammi C, la Sala A, Volterrani M, Gatta L, Antelmi A, Feraco A, Caminiti G, Marazzi G, Vitale C, Caprio M, Rosano GM.

Eur J Heart Fail. 2011 Jun;13(6):642-50. doi: 10.1093/eurjhf/hfr026.

12.

Non-pegylated liposomal doxorubicin (Myocet®) in patients with poor-risk aggressive B-cell non-Hodgkin lymphoma.

Dell'Olio M, Scalzulli RP, Sanpaolo G, Nobile M, Mantuano FS, La Sala A, D'Arena G, Miraglia E, Lucania A, Mastrullo L, Nicola C.

Leuk Lymphoma. 2011 Jul;52(7):1222-9. doi: 10.3109/10428194.2011.572321. Epub 2011 May 25.

PMID:
21612383
13.

ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation.

Gorini S, Callegari G, Romagnoli G, Mammi C, Mavilio D, Rosano G, Fini M, Di Virgilio F, Gulinelli S, Falzoni S, Cavani A, Ferrari D, la Sala A.

Blood. 2010 Nov 25;116(22):4492-500. doi: 10.1182/blood-2009-12-260828. Epub 2010 Jul 28.

14.

Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.

Giardino Torchia ML, Ciaglia E, Masci AM, Vitiello L, Fogli M, la Sala A, Mavilio D, Racioppi L.

PLoS One. 2010 Jun 10;5(6):e11052. doi: 10.1371/journal.pone.0011052.

15.

Cell survival: is not all about apoptosis.

la Sala A, Rosano GM.

Eur Heart J. 2010 Feb;31(4):503; author reply 503-4. doi: 10.1093/eurheartj/ehp524. Epub 2009 Dec 1. No abstract available.

PMID:
19952002
16.

Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function.

la Sala A, He J, Laricchia-Robbio L, Gorini S, Iwasaki A, Braun M, Yap GS, Sher A, Ozato K, Kelsall B.

J Exp Med. 2009 Jun 8;206(6):1227-35. doi: 10.1084/jem.20080912. Epub 2009 Jun 1. Erratum in: J Exp Med. 2009 Jul 6;206(7):1635.

17.

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

Federico M, Luminari S, Iannitto E, Polimeno G, Marcheselli L, Montanini A, La Sala A, Merli F, Stelitano C, Pozzi S, Scalone R, Di Renzo N, Musto P, Baldini L, Cervetti G, Angrilli F, Mazza P, Brugiatelli M, Gobbi PG; HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

J Clin Oncol. 2009 Feb 10;27(5):805-11. doi: 10.1200/JCO.2008.17.0910. Epub 2009 Jan 5.

PMID:
19124807
18.

Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia.

D'Arena G, Vigliotti ML, Dell'Olio M, Villa MR, Mantuano S, Scalzulli PR, La Sala A, Abbadessa A, Mastrullo L, Cascavilla N.

Eur J Haematol. 2009 Mar;82(3):235-9. doi: 10.1111/j.1600-0609.2008.01187.x. Epub 2008 Nov 20.

PMID:
19067738
19.

The airway response to deep inspirations decreases with COPD severity and is associated with airway distensibility assessed by computed tomography.

Scichilone N, La Sala A, Bellia M, Fallano K, Togias A, Brown RH, Midiri M, Bellia V.

J Appl Physiol (1985). 2008 Sep;105(3):832-8. doi: 10.1152/japplphysiol.01307.2007. Epub 2008 Jul 10.

20.

Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion.

Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, Rosano G, Mendelsohn ME, Jaffe IZ.

Circ Res. 2008 Jun 6;102(11):1359-67. doi: 10.1161/CIRCRESAHA.108.174235. Epub 2008 May 8.

21.

Shaping immune responses through the activation of dendritic cells' P2 receptors.

Ferrari D, Gorini S, Callegari G, la Sala A.

Purinergic Signal. 2007 Mar;3(1-2):99-107. doi: 10.1007/s11302-006-9024-0. Epub 2006 Aug 12.

22.

Hydrolysis of extracellular ATP and immune suppression: humans versus mice.

Gorini S, la Sala A.

Blood. 2008 Jan 15;111(2):964-5; author reply 965-6. doi: 10.1182/blood-2007-09-111203. No abstract available.

23.

Clinical implications of airway hyperresponsiveness in COPD.

Scichilone N, Battaglia S, La Sala A, Bellia V.

Int J Chron Obstruct Pulmon Dis. 2006;1(1):49-60. Review.

24.

Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis.

Leon F, Contractor N, Fuss I, Marth T, Lahey E, Iwaki S, la Sala A, Hoffmann V, Strober W, Kelsall BL.

J Immunol. 2006 Nov 15;177(10):6974-82.

25.

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.

Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S, Farschi A, Follmann D, Gregg R, Kovacs C, Marcenaro E, Pende D, Moretta A, Fauci AS.

J Exp Med. 2006 Oct 2;203(10):2339-50. Epub 2006 Sep 25.

26.

MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.

Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.

Clin Cancer Res. 2006 Jan 15;12(2):529-35.

27.

CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16.

Stabile E, Kinnaird T, la Sala A, Hanson SK, Watkins C, Campia U, Shou M, Zbinden S, Fuchs S, Kornfeld H, Epstein SE, Burnett MS.

Circulation. 2006 Jan 3;113(1):118-24. Epub 2005 Dec 27. Erratum in: Circulation. 2006 Apr 18;113(15):e711.

PMID:
16380545
28.

Activation of human eosinophils via P2 receptors: novel findings and future perspectives.

Ferrari D, la Sala A, Panther E, Norgauer J, Di Virgilio F, Idzko M.

J Leukoc Biol. 2006 Jan;79(1):7-15. Epub 2005 Oct 21. Review.

PMID:
16244111
30.

Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide.

Musto P, Falcone A, Sanpaolo G, Guglielmelli T, Zambello R, Balleari E, Catalano L, Spriano M, Cavallo F, La Sala A, Mantuano S, Nobile M, Melillo L, Scalzulli PR, Dell'Olio M, Bodenizza C, Greco MM, Carella AM Jr, Merla E, Carella AM, Boccadoro M, Cascavilla N, Palumbo A.

Leuk Res. 2006 Mar;30(3):283-5. Epub 2005 Aug 18.

31.

Primary breast lymphoma: outcome of 7 patients and a review of the literature.

Vigliotti ML, Dell'olio M, La Sala A, Di Renzo N.

Leuk Lymphoma. 2005 Sep;46(9):1321-7. Review.

PMID:
16109610
32.

Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes.

Musto P, Lanza F, Balleari E, Grossi A, Falcone A, Sanpaolo G, Bodenizza C, Scalzulli PR, La Sala A, Campioni D, Ghio R, Cascavilla N, Carella AM.

Br J Haematol. 2005 Jan;128(2):204-9.

PMID:
15638854
33.

Primary central nervous system lymphoma (PCNSL) in immunocompetent adults: analysis of a retrospective series of patients treated using idarubicin-containing regimen and radiotherapy.

Vigliotti ML, Dell'Olio M, La Sala A, Romano G, Tartarone A, Mele G, Musto C, Carella AM, Di Renzo N.

Hematol J. 2004;5(5):453-5. Review. No abstract available.

PMID:
15448676
34.

Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Perla G, Minervini MM, Cascavilla N, Dell'Olio M, La Sala A, Mantuano S, Melillo L, Nobile M, Scalzulli PR, Bisceglia M, Carella AM.

Leuk Lymphoma. 2004 Jun;45(6):1219-22.

PMID:
15360005
35.

Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Cascavilla N, Melillo L, Scalzulli PR, Dell'Olio M, La Sala A, Mantuano S, Nobile M, Carella AM.

Leuk Lymphoma. 2003 Sep;44(9):1545-8.

PMID:
14565658
36.

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, La Sala A, Perla G, Carella AM.

Br J Haematol. 2003 Jul;122(2):269-71.

PMID:
12846896
37.

Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.

Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A, Miller JM, Shou M, Epstein SE, Fuchs S.

Circulation. 2003 Jul 15;108(2):205-10. Epub 2003 Jun 23.

PMID:
12821542
38.

Alerting and tuning the immune response by extracellular nucleotides.

la Sala A, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G.

J Leukoc Biol. 2003 Mar;73(3):339-43. Review.

PMID:
12629147
39.

Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells.

Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G, Norgauer J.

Blood. 2003 May 15;101(10):3985-90. Epub 2002 Nov 21.

40.

Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors.

Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A, Girolomoni G, Panther E, Norgauer J.

Blood. 2002 Aug 1;100(3):925-32.

41.

Expression and function of histamine receptors in human monocyte-derived dendritic cells.

Idzko M, la Sala A, Ferrari D, Panther E, Herouy Y, Dichmann S, Mockenhaupt M, Di Virgilio F, Girolomoni G, Norgauer J.

J Allergy Clin Immunol. 2002 May;109(5):839-46.

PMID:
11994709
42.
43.

Regulatory activity of autocrine IL-10 on dendritic cell functions.

Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G.

J Immunol. 2001 Apr 1;166(7):4312-8.

44.

Functional topography of discrete domains of human CD38.

Ausiello CM, Urbani F, Lande R, la Sala A, Di Carlo B, Baj G, Surico N, Hilgers J, Deaglio S, Funaro A, Malavasi F.

Tissue Antigens. 2000 Dec;56(6):539-47.

PMID:
11169244
45.

Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses.

la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G.

J Immunol. 2001 Feb 1;166(3):1611-7.

46.

The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release.

Ferrari D, La Sala A, Chiozzi P, Morelli A, Falzoni S, Girolomoni G, Idzko M, Dichmann S, Norgauer J, Di Virgilio F.

FASEB J. 2000 Dec;14(15):2466-76.

PMID:
11099464
47.

Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis.

la Sala A, Corinti S, Federici M, Saragovi HU, Girolomoni G.

J Leukoc Biol. 2000 Jul;68(1):104-10.

PMID:
10914496
48.

Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.

Ausiello CM, Lande R, Urbani F, la Sala A, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A.

Infect Immun. 1999 Aug;67(8):4064-71.

49.

Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens.

Ausiello CM, Lande R, la Sala A, Urbani F, Cassone A.

J Infect Dis. 1998 Aug;178(2):466-70.

PMID:
9697728
50.

Supplemental Content

Loading ...
Support Center